TMEM60 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.62360000000228E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.973200E-01
Normal-vs-Stage2
1.52664999999441E-05
Normal-vs-Stage3
2.881000E-01
Normal-vs-Stage4
4.503800E-01
Stage1-vs-Stage2
4.153000E-01
Stage1-vs-Stage3
5.029600E-01
Stage1-vs-Stage4
9.091800E-01
Stage2-vs-Stage3
5.013400E-01
Stage2-vs-Stage4
3.886600E-01
Stage3-vs-Stage4
4.306000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.58040000000281E-05
Normal-vs-AfricanAmerican
5.899800E-02
Normal-vs-Asian
2.480500E-03
Caucasian-vs-AfricanAmerican
7.275400E-01
Caucasian-vs-Asian
4.182300E-02
AfricanAmerican-vs-Asian
4.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.16660000002178E-06
Normal-vs-Female
1.794540E-04
Male-vs-Female
4.738400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.064000E-01
Normal-vs-Age(41-60Yrs)
2.262600E-01
Normal-vs-Age(61-80Yrs)
1.51009999949103E-07
Normal-vs-Age(81-100Yrs)
1.936070E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.136200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.112770E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.949200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.243770E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.463640E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.310000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.439810E-04
Normal-vs-Daily Drinker
3.037300E-04
Normal-vs-Weekly Drinker
1.480630E-03
Normal-vs-Occasional Drinker
5.662400E-02
Normal-vs-Social Drinker
9.236000E-01
Non Drinker-vs-Daily Drinker
6.726600E-01
Non Drinker-vs-Weekly Drinker
7.912600E-01
Non Drinker-vs-Occasional Drinker
1.993790E-01
Non Drinker-vs-Social Drinker
2.007700E-02
Daily Drinker-vs-Weekly Drinker
9.074000E-01
Daily Drinker-vs-Occasional Drinker
3.170200E-01
Daily Drinker-vs-Social Drinker
3.282400E-02
Weekly Drinker-vs-Occasional Drinker
3.213600E-01
Weekly Drinker-vs-Social Drinker
5.173800E-02
Occasional Drinker-vs-Social Drinker
2.464200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.652800E-01
Normal-vs-Grade 2
7.492200E-01
Normal-vs-Grade 3
3.413400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.552000E-01
Grade 1-vs-Grade 3
8.576200E-01
Grade 1-vs-Grade 4
4.652800E-01
Grade 2-vs-Grade 3
5.189400E-01
Grade 2-vs-Grade 4
7.492200E-01
Grade 3-vs-Grade 4
3.413400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.01359999996154E-06
Normal-vs-NonDiabetic
1.185620E-04
Diabetic-vs-NonDiabetic
3.068100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.179900E-03
Normal-vs-NoPancreatitis
1.78918999999E-05
Pancreatitis-vs-NoPancreatitis
5.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.460940E-03
Normal-vs-N1
1.62427000000021E-05
N0-vs-N1
7.175400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.284200E-01
Normal-vs-TP53-NonMutant
5.745600E-01
TP53-Mutant-vs-TP53-NonMutant
2.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
